Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of inactivated COVID-19 vaccine in adults with chronic underlying diseases
ChiCTR2200058281Phase 4Recruiting
- Sponsor
- Yunnan University
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of coronavac and BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Yunnan University. Started Jul 2021; status: recruiting.
02
Drugs
coronavacBBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200058281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058281.